HPV-based Screening Among Women 23-29 Years of Age

NARecruitingINTERVENTIONAL
Enrollment

180,000

Participants

Timeline

Start Date

November 16, 2020

Primary Completion Date

December 31, 2038

Study Completion Date

December 31, 2038

Conditions
Human Papilloma VirusCervical Intraepithelial NeoplasiaCervical Cancer
Interventions
DIAGNOSTIC_TEST

HPV testing

All women age 23-29 resident in the pilot counties will be invited to HPV screening as of the study start date. The same invitation as currently used for women aged 30 and upwards will be used. This information clearly states that it is possible to opt out of the program and that data from the screening program will be collected to regional and national quality registers who will systematically evaluate the quality of the care. At the screening station, the samples are collected identically regardless of primary screening test used - there is no change in the procedures used neither for the woman or for the midwives taking the sample. HPV testing will be performed using the same purchased, CE-marked and accredited HPV screening platforms as currently used for women aged 30 and upwards. The cytology is according to the liquid-based cytology method.

Trial Locations (2)

221 00

ACTIVE_NOT_RECRUITING

Region of Skåne, Lund

102 39

RECRUITING

Region Stockholm, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER